pharma · Juvenile idiopathic arthritis · juvenile idiopathic arthritis
Alfasigma
Alfasigma S.p.A.
Alfasigma clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- BOLOGNA, IT
- Employees
- 2,481
- Programs
- 8
- Drugs
- 8
- Patents
- 25
Alfasigma projects
6 ClinicalTrials.gov programs sponsored by Alfasigma.
Alfasigma has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Filgotinib
Alfasigma S.p.A.
Axial Spondyloarthritis
1 trial -
GLPG0634-CL-329
Alfasigma S.p.A.
Polyarticular-course juvenile idiopathic arthritis
1 trial -
GLPG0634-CL-331
Alfasigma S.p.A.
Ulcerative colitis
1 trial -
GLPG0634-CL-333
Alfasigma S.p.A.
Juvenile idiopathic arthritis
1 trial -
GS-US-417-0304
Alfasigma S.p.A.
Rheumatoid arthritis
1 trial -
GS-US-418-3899
Alfasigma S.p.A.
Ulcerative Colitis (UC)
1 trial
Frequently asked questions
How many clinical projects does Alfasigma have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.